Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.00
-0.21 (-0.99%)
Mar 27, 2026, 11:06 AM EDT - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.63 billion as of March 27, 2026. Its market cap has increased by 151.23% in one year.
Market Cap
2.63B
Enterprise Value
1.87B
1-Year Change
151.23%
Ranking
Category
Stock Price
$21.00
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $2.63B, an increase of 271.75%. That is a compound annual growth rate of 17.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 2.69B | 4.55% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 2.96B |
| Viridian Therapeutics | 2.88B |
| Vera Therapeutics | 2.87B |
| Tarsus Pharmaceuticals | 2.86B |
| Tango Therapeutics | 2.83B |
| IDEAYA Biosciences | 2.82B |
| Arcutis Biotherapeutics | 2.78B |
| Travere Therapeutics | 2.58B |